ES2911226T3 - Mejoras en los dispositivos de bolo para el suministro de principios activos en animales - Google Patents

Mejoras en los dispositivos de bolo para el suministro de principios activos en animales Download PDF

Info

Publication number: ES2911226T3
Authority: ES; Spain
Prior art keywords: active; tablets; bolus; tablet; animal
Prior art date: 2008-11-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

ES09829371T

Other languages

English (en)

Spanish (es)

Inventor

Wayne Leech

William Pomroy

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Elanco New Zeeland

Original Assignee

Elanco New Zeeland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-11-25

Filing date

2009-06-29

Publication date

2022-05-18

2009-06-29 Application filed by Elanco New Zeeland filed Critical Elanco New Zeeland

2022-05-18 Application granted granted Critical

2022-05-18 Publication of ES2911226T3 publication Critical patent/ES2911226T3/es

Status Active legal-status Critical Current

2029-06-29 Anticipated expiration legal-status Critical

Links

241001465754 Metazoa Species 0.000 title claims abstract description 53
239000004480 active ingredient Substances 0.000 title claims description 9
239000013543 active substance Substances 0.000 claims abstract description 17
230000000507 anthelmentic effect Effects 0.000 claims description 4
241000282849 Ruminantia Species 0.000 claims description 3
235000015872 dietary supplement Nutrition 0.000 claims 1
239000003814 drug Substances 0.000 description 15
229940079593 drug Drugs 0.000 description 14
230000015556 catabolic process Effects 0.000 description 10
238000006731 degradation reaction Methods 0.000 description 10
241000283690 Bos taurus Species 0.000 description 9
239000000203 mixture Substances 0.000 description 7
229910002804 graphite Inorganic materials 0.000 description 6
239000010439 graphite Substances 0.000 description 6
244000045947 parasite Species 0.000 description 6
241000894006 Bacteria Species 0.000 description 4
244000309466 calf Species 0.000 description 4
210000004767 rumen Anatomy 0.000 description 4
239000000126 substance Substances 0.000 description 4
IBSREHMXUMOFBB-JFUDTMANSA-N 5u8924t11h Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O3)C=C[C@H](C)[C@@H](C(C)C)O4)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 IBSREHMXUMOFBB-JFUDTMANSA-N 0.000 description 3
239000005660 Abamectin Substances 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
229950008167 abamectin Drugs 0.000 description 3
238000000034 method Methods 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
230000001568 sexual effect Effects 0.000 description 3
206010061217 Infestation Diseases 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
238000009472 formulation Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
230000003071 parasitic effect Effects 0.000 description 2
125000006850 spacer group Chemical group 0.000 description 2
210000002784 stomach Anatomy 0.000 description 2
AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 1
SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 1
229910002016 Aerosil® 200 Inorganic materials 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
206010059866 Drug resistance Diseases 0.000 description 1
HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
LAZPBGZRMVRFKY-HNCPQSOCSA-N Levamisole hydrochloride Chemical compound Cl.C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 LAZPBGZRMVRFKY-HNCPQSOCSA-N 0.000 description 1
WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
229910045601 alloy Inorganic materials 0.000 description 1
239000000956 alloy Substances 0.000 description 1
229940124339 anthelmintic agent Drugs 0.000 description 1
239000000921 anthelmintic agent Substances 0.000 description 1
230000003466 anti-cipated effect Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
239000000560 biocompatible material Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000010276 construction Methods 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
229940099112 cornstarch Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
230000000694 effects Effects 0.000 description 1
230000008029 eradication Effects 0.000 description 1
230000029142 excretion Effects 0.000 description 1
239000012530 fluid Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000002513 implantation Methods 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
229960002418 ivermectin Drugs 0.000 description 1
230000000366 juvenile effect Effects 0.000 description 1
229960001614 levamisole Drugs 0.000 description 1
229960003734 levamisole hydrochloride Drugs 0.000 description 1
230000007774 longterm Effects 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
239000000463 material Substances 0.000 description 1
238000002483 medication Methods 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
229910001092 metal group alloy Inorganic materials 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
229940069328 povidone Drugs 0.000 description 1
229940079832 sodium starch glycolate Drugs 0.000 description 1
229920003109 sodium starch glycolate Polymers 0.000 description 1
239000008109 sodium starch glycolate Substances 0.000 description 1
241000894007 species Species 0.000 description 1
229940032147 starch Drugs 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000003068 static effect Effects 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

ES09829371T 2008-11-25 2009-06-29 Mejoras en los dispositivos de bolo para el suministro de principios activos en animales Active ES2911226T3 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ573143A NZ573143A (en)	2008-11-25	2008-11-25	Improvements in delivery devices
PCT/NZ2009/000129 WO2010062190A1 (en)	2008-11-25	2009-06-29	Improvements in bolus devices for the delivery of active agents to animals

Publications (1)

Publication Number	Publication Date
ES2911226T3 true ES2911226T3 (es)	2022-05-18

Family

ID=42040796

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES09829371T Active ES2911226T3 (es)	2008-11-25	2009-06-29	Mejoras en los dispositivos de bolo para el suministro de principios activos en animales

Country Status (8)

Country	Link
US (2)	US8329206B2 (pt)
EP (2)	EP2361053B1 (pt)
AU (2)	AU2009320500B2 (pt)
BR (1)	BRPI0921187A2 (pt)
ES (1)	ES2911226T3 (pt)
NZ (1)	NZ573143A (pt)
WO (2)	WO2010062190A1 (pt)
ZA (2)	ZA201104723B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN103126886A (zh) *	2011-05-13	2013-06-05	中国农业科学院北京畜牧兽医研究所	一种仔猪安抚剂释放盒
US11529310B2 (en)	2020-12-08	2022-12-20	Ruminant Biotech Corp Limited	Devices and methods for delivery of substances to animals
AT528167A1 (de)	2024-03-15	2025-10-15	Smaxtec Animal Care Gmbh	Sondenvorrichtung mit zumindest einer Reservoir-Einheit

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2416467A1 (fr) *	1978-02-03	1979-08-31	Ici Ltd	Procede et appareil pour l'analyse de gaz
US4418686A (en) *	1979-08-01	1983-12-06	Child Laboratories Inc.	Implant for inhibiting mastitis in dairy cattle
US4381780A (en)	1981-01-19	1983-05-03	Research Corporation	Sustained release delivery system
GR851195B (pt) *	1984-06-02	1985-11-25	Castex Prod
GB8514666D0 (en)	1985-06-11	1985-07-10	Coopers Animal Health	Agent delivery systems
AU605482B2 (en) *	1986-04-17	1991-01-17	Castex Products Limited	Pellet for administration to ruminants
US5219572A (en) *	1989-03-17	1993-06-15	Pitman-Moore, Inc.	Controlled release delivery device for macromolecular proteins
GB9023270D0 (en) *	1990-10-25	1990-12-05	Castex Prod	Magnesium manganese alloy
US5314696A (en) *	1991-06-27	1994-05-24	Paulos Manley A	Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DK0739198T3 (da) *	1994-01-20	2004-01-26	Agres Ltd	Anordning til indgivelse af gavnlige materialer til drøvtyggere
GB9801141D0 (en) *	1998-01-21	1998-03-18	Porter William L	Bolus for ruminent animals
US6030367A (en) *	1999-03-22	2000-02-29	Bracco Research	Plunger rod
GB0111391D0 (en) *	2001-05-10	2001-07-04	Porter William L	Pulse release bolus
NZ519363A (en)	2002-06-05	2004-02-27	Agres Ltd	A novel drug dosing regimen
CN1964748A (zh) *	2004-04-06	2007-05-16	苏莫迪克斯公司	用于生物活性剂的涂料组合物

2008
- 2008-11-25 NZ NZ573143A patent/NZ573143A/en unknown
2009
- 2009-06-29 BR BRPI0921187A patent/BRPI0921187A2/pt not_active IP Right Cessation
- 2009-06-29 AU AU2009320500A patent/AU2009320500B2/en not_active Ceased
- 2009-06-29 US US13/131,259 patent/US8329206B2/en active Active
- 2009-06-29 WO PCT/NZ2009/000129 patent/WO2010062190A1/en not_active Ceased
- 2009-06-29 ES ES09829371T patent/ES2911226T3/es active Active
- 2009-06-29 EP EP09829371.5A patent/EP2361053B1/en active Active
- 2009-08-21 US US13/131,260 patent/US20110287081A1/en not_active Abandoned
- 2009-08-21 AU AU2009320501A patent/AU2009320501B2/en not_active Expired - Fee Related
- 2009-08-21 EP EP09829372.3A patent/EP2361055A4/en not_active Withdrawn
- 2009-08-21 WO PCT/NZ2009/000173 patent/WO2010062191A1/en not_active Ceased
2011
- 2011-06-24 ZA ZA2011/04723A patent/ZA201104723B/en unknown
- 2011-06-24 ZA ZA2011/04724A patent/ZA201104724B/en unknown

Also Published As

Publication number	Publication date
WO2010062191A1 (en)	2010-06-03
WO2010062190A1 (en)	2010-06-03
ZA201104723B (en)	2012-12-27
US20110280923A1 (en)	2011-11-17
EP2361053A1 (en)	2011-08-31
EP2361053A4 (en)	2013-12-25
EP2361053B1 (en)	2022-01-19
NZ573143A (en)	2010-03-26
AU2009320501A1 (en)	2011-07-07
EP2361055A4 (en)	2013-12-18
AU2009320500B2 (en)	2014-09-25
ZA201104724B (en)	2012-12-27
AU2009320501B2 (en)	2014-08-21
US20110287081A1 (en)	2011-11-24
US8329206B2 (en)	2012-12-11
EP2361055A1 (en)	2011-08-31
BRPI0921187A2 (pt)	2016-02-23
AU2009320500A1 (en)	2011-07-07

Publication	Publication Date	Title
ES2752923T3 (es)	2020-04-06	Cápsulas de liberación prolongada
ES2742815T3 (es)	2020-02-17	Uso antiparasitario de compuestos de isoxazolina
HU211208B (en)	1995-11-28	Release device above all for biologically active materials with a liquid impermeable casing
AU763614B2 (en)	2003-07-31	Pellet implant system for immediate and delayed release of antiparasitic drug
RS63675B1 (sr)	2022-11-30	Sistemi za isporuku leka i metode za lečenje raka bešike gemcitabinom
RU2535012C1 (ru)	2014-12-10	Способ нормализации тромбоцитарной активности у новорожденных телят с железодефицитной анемией
ES2911226T3 (es)	2022-05-18	Mejoras en los dispositivos de bolo para el suministro de principios activos en animales
ES2444598T3 (es)	2014-02-25	Uso de glicósido de 1,25-dihidroxivitamina-D3 en animales lactantes
ES2757299T3 (es)	2020-04-28	Suministro de fármaco anti-inflamatorio no esteroideo de liberación sostenida
ES2902795T3 (es)	2022-03-29	Composición para uso crónico como compuesto para aumentar de peso
Rowland	2011	Use of a deslorelin implant to control aggression in a male bearded dragon (Pogona vitticeps)
US20150351428A1 (en)	2015-12-10	Methods and compositions for orally dosing postnatal swine
Mashima et al.	2000	Pet fish formulary
CN103690546B (zh)	2016-05-18	一种猫用预防和治疗弓形虫病的口腔崩解片及其制备方法
RU2228176C2 (ru)	2004-05-10	Способ лечения мастита у коров
NZ576414A (en)	2010-08-27	Bolus in form of plural dosage media connected by flexible material
WO2008013235A1 (fr)	2008-01-31	Procédé de suppression de parasites sur la surface corporelle de poissons
McGettigan	2019	Ovarid: why was this drug withdrawn?
CN106491625B (zh)	2019-01-04	一种治疗罗非鱼三代虫病的复合制剂
RU2327464C1 (ru)	2008-06-27	Способ лечения аэромоноза у рыб
Melnychuk	2015	Therapeutical efficacy of medicaments on the basis of ivermectin at trichurosic invasion of pigs
Loh	2015	Treatment modalities and medications used in tropical fish and koi diseases.
Ferreira	2018	Controlling wireworm in spring
HU217811B (hu)	2000-04-28	Eljárás metil-5(6)-benzoil-2-benzimidazol-karbamátot tartalmazó gélformájú, antiparazitikus hatású állatgyógyászati készítmény előállítására
WO2021152198A1 (es)	2021-08-05	Sustancia acaricida natural para el control de la varroosis en colmenas